© 2022 MJH Life Sciences™ and Urology Times. All rights reserved.
FDA approves therapy for advanced renal cell carcinoma
The FDA has approved GlaxoSmithKline's pazopanib (Votrient) to treat patients with advanced renal cell carcinoma.
© 2022 MJH Life Sciences™ and Urology Times. All rights reserved.
The FDA has approved GlaxoSmithKline's pazopanib (Votrient) to treat patients with advanced renal cell carcinoma.